Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2012-07-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
From experience with parental guidance, data from the observation of children of patients with BPD and psychosocial programs directed to patients BPD, we have built for preventive intervention. The Supportive Program for Mothers with BPD (SuPMother-B) consists of 10 group sessions providing information (education, childcare, care specific to BPD) and promotes mother-child interactions (observation, games).
Purpose: Compare the effect of a program (SuPMother-B) group, of 10 sessions, offered to mothers with a BPD in addition to a minimal intervention (diagnostic announcement and provision of health care resources) on behavior withdrawal of children at 6 months compared to a group of mothers receiving only minimal intervention.
Primary outcome: Difference at 6 months between the experimental and control groups on scores on the assessment scale withdrawal (Alarm Distress Baby (ADBB)).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parenting Skills for Mothers With Borderline Personality Disorder (BPD)
NCT04169048
Parenting Skills for Mothers With Borderline Personality Disorder: A Newly Developed Group Training Program
NCT02935218
Preschooler Emotion Regulation in the Context of Maternal Borderline Personality Disorder
NCT03060902
Mother-Infant Intervention for Postpartum Depression and Associated Mother-Infant Relationship Dysfunction
NCT02057627
Early Intervention to Protect the Mother-Child Relationship After Postpartum Depression
NCT05209789
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BPD prevention
Supportive Program for Mother with BPD (SuPMother-B) : BPD mothers participate to prevention program in groups or/and house calls.
Supportive Program for Mother with BPD (SuPMother-B).
The development of the program is based on several principles: group process, groupware, mentalization, parental values, behavioral strategies and information on the child's needs, knowledge of the BPD and the strategies of get better. The program will last 10 sessions of group of about 2h.
Minimal intervention. All study participants receive an individual interview about 45 minutes with a psychiatrist for three objectives: information on the diagnosis of BPD, information on resources for health care and educational aids.
Usual care of BPD mothers
BPD mothers don't participate to Supportive Program (SuPMother-B).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Supportive Program for Mother with BPD (SuPMother-B).
The development of the program is based on several principles: group process, groupware, mentalization, parental values, behavioral strategies and information on the child's needs, knowledge of the BPD and the strategies of get better. The program will last 10 sessions of group of about 2h.
Minimal intervention. All study participants receive an individual interview about 45 minutes with a psychiatrist for three objectives: information on the diagnosis of BPD, information on resources for health care and educational aids.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women with children and at least one child aged 2 months to 2 years, Borderline Personality Disorder with SIDP (Structured Interview for DSM Personality Disorders)
* age above 18 years
* written consent
Child:
* ages between 2 months and 2 years,
* parental consent for research participation.
Exclusion Criteria
* chronic psychotic disorder, major depressive disorder, current mania or hypomania,
* legal protection,
* if no child can be included, the mother cannot be included.
Child :
•major psychomotor development disorder or psychiatric disorder according to the investigator.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
CHEYNIER
Role: PRINCIPAL_INVESTIGATOR
UTAMS PMI Empalot
LATOUR
Role: PRINCIPAL_INVESTIGATOR
UTAMS PMI Reynerie
BLEY-RIBET
Role: PRINCIPAL_INVESTIGATOR
UTAMS PMI Bonnefoy
MULQUIN
Role: PRINCIPAL_INVESTIGATOR
UTAMS PMI Rangueil
KOUBAA
Role: PRINCIPAL_INVESTIGATOR
UTAMS PMI Cazères
BERTIN
Role: PRINCIPAL_INVESTIGATOR
UTAMS PMI Montauban
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de psychiatrie de l'enfant et de l'adolescent - Hôpital La Grave - centre Hospitalier de Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Interregional PHRC 2011
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
11 199 08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.